Single‐Cell Atlas of Subchondral Bone Marrow Lesions Reveals Proteostasis Dysfunction as a Druggable Mechanism for Early Osteoarthritis

Read full text
Authors: Hailun Xu, Ting He, Yu Qian, Jia Li, Bowei Ni, Xiaojie Xu, Hao Wang, Peng Wang, Guoqing Cao, Siqi Ying, Guangyu Ding, Rong Wang
+9 more Zenghui Gu, W. Li, Zhentao Man, Houfeng Zheng, Zhaohua Zhu, Z Li, Q. Meng, Chao Zheng, Liu Yang
Cited by: 2
References: 35

Abstract

ABSTRACT Subchondral bone marrow lesions (BMLs) constitute a pathognomonic imaging feature of both incipient and progressive osteoarthritis (OA). However, the pathological features and molecular mechanisms underlying BMLs remain poorly characterized. Here, we innovatively established and dynamically characterized a standardized mouse model, simulating human BMLs on magnetic resonance imaging (MRI) that correlates significantly with cartilage degeneration, while revealing substantial aberrant bone matrix accumulation within BML regions. By establishing an osteochondral single‐cell atlas of mouse knee joints during BML development, we found that proteasome dysfunction and abnormal secretion of misfolded collagen, driven by dysregulated heat shock protein 70 (HSP70) and deubiquitinase 19 (USP19) expression in osteoarthritic subchondral osteoblasts, constitute a key mechanism of BML formation. Furthermore, cell‐cell communication and Col10a1‐Cre; R26 tdt+ fate‐mapping analyses uncovered that osteoblast‐secreted WNT5A mediates crosstalk with hypertrophic chondrocytes (HTCs), accelerating their hypertrophy and cell death. Critically, pharmacological HSP70 targeting by TRC051384 inhibited collagen misfolding/secretion, preventing BML formation. Notably, results of Mendelian randomization demonstrated a significant correlation between proteasome gene expression and OA risk in humans, further supporting a potential role of proteasome dysfunction in BML pathogenesis. Collectively, these data reveal mechanisms underlying BML formation and therapeutic targets for early OA intervention.

Fields of Study & Subjects

Osteoarthritis Treatment and Mechanisms Rheumatoid Arthritis Research and Therapies Autoimmune and Inflammatory Disorders Research

Publication details

Journal / source
Advanced Science
Publisher
Wiley
Volume
13
Issue
26
Pages
e16720–e16720
Publication date
13 February 2026
Language
EN